In agreement, a recent study, which analyzed the therapy-induced evolution of human lung cancer by single-cell RNA sequencing (scRNA-seq), revealed that TYMP expression was increased in progressive metastatic lung cancer compared to the NSCLC biopsy samples that were obtained from patients before initiating systemic targeted therapy [53]. Here, TYMP is linked to lung carcinoma.